Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of the study is to evaluate the efficacy of Voluven® in the prevention of maternal hypotension in women undergoing spinal anesthesia for cesarean section

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fresenius Kabi
• Treatments: Anesthetics; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• elective cesarean section applying spinal anesthesia

• ≥ week 37 of gestation

• Singleton pregnancy

Exclusion Criteria:

• Suspicion of any hypertensive disease

• Parturient in labor